Metraipolis › archive › dc_b91ff862f656

Design and In Vitro Evaluation of Novel GC373-like SARS-CoV-2 Main Protease Inhibitors — Europe PMC PMID:41751406

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41751406
DOI
10.3390/cimb48020142
License (as archived)
solo-consultazione
Archived
2026-11-06T11:15:00.100Z
SHA-256 of the archived text
c78317cfe633538143dfd7944e03d133c0564664ab611cd9d1735e84dacbc301
Stable URL of this page
https://metraipolis.com/documento/dc_b91ff862f656

How to cite

Design and In Vitro Evaluation of Novel GC373-like SARS-CoV-2 Main Protease Inhibitors — Europe PMC PMID:41751406 — Europe PMC (en), https://europepmc.org/article/MED/41751406 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b91ff862f656 (Metraipolis archive dc_b91ff862f656, sha256 c78317cfe633538143dfd7944e03d133c0564664ab611cd9d1735e84dacbc301)
BibTeX
@misc{dcb91ff862f656,
  title = {Design and In Vitro Evaluation of Novel GC373-like SARS-CoV-2 Main Protease Inhibitors — Europe PMC PMID:41751406},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41751406},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b91ff862f656; sha256 c78317cfe633538143dfd7944e03d133c0564664ab611cd9d1735e84dacbc301},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751406. Agents can read the archived copy with the MCP tool read_document.